ImpediMed Limited, announced today that it has entered into agreements to establish a Medical Advisory Board to advise the Company on the design of clinical trials for the use of bioimpedance spectroscopy (BIS) in fluid detection for chronic heart failure patients.
Medical device company dorsaVi today announced that Transport for London (TFL), the operator of the London Underground rail network, has signed its third and largest contract with dorsaVi to identify manual handling tasks that are contributing to increased risk of musculoskeletal injury.
Wearable medical device company dorsaVi today announced that it has signed two additional industry leaders in the transportation sector in the United Kingdom, with Jaguar Land Rover and Toyota commencing ViSafe workplace assessments.
Medical device company, dorsaVi Ltd, today released its latest White Paper Comparative Study, looking into the impact of workplace back injuries and the use of their ViSafe technology by construction business, VINCI Construction UK, to objectively assess high risk tasks with hard data.
Australia's emergence as a hub for online marketplaces has been highlighted by Sydney's DesignCrowd reaching 500,000 registered suppliers, yet still being only the second-largest locally founded business in the design vertical.
With the average rep juggling 80-100 physicians in one territory, multiple communication channels and a pharma market that’s changing every day, it’s not surprising that CRM suggestions have emerged as one of the most impressive tools in today’s pharma marketing arsenal.
dorsaVi is an ASX listed health-science company that was developed by physiotherapist Andrew Ronchi. Its revolutionary wireless technology is designed to accurately and objectively measure and analyse human movement.